Michael Keller

Title: Michael Keller: Innovator in Mycobacterial and HPV Research

Introduction

Michael Keller is a prominent inventor based in Washington, DC. He has made significant contributions to the field of medical research, particularly in the development of innovative therapies targeting mycobacterial infections and human papillomavirus (HPV). With a total of three patents to his name, Keller's work is paving the way for advancements in immunotherapy.

Latest Patents

Keller's latest patents include "Mycobacterial antigen compositions and methods of use." This patent focuses on mycobacterial polynucleotides and polypeptides, including their fragments and variants. It also discusses engineered cells that expand T-cells ex vivo, along with methods for their use. Another notable patent is "Generating HPV antigen-specific cells from a naive T cell population," which outlines safe, rapid, and efficient methods for producing antigen-specific T cells that recognize HPV antigens.

Career Highlights

Michael Keller is currently affiliated with the Children's National Medical Center, where he continues to push the boundaries of medical research. His work is instrumental in developing new therapeutic strategies that harness the immune system to combat infections and diseases.

Collaborations

Keller collaborates with esteemed colleagues, including Catherine M. Bollard and Conrad Russell Cruz. Their combined expertise enhances the research efforts and contributes to the success of their innovative projects.

Conclusion

Michael Keller's contributions to medical research through his patents and collaborations highlight his role as a key innovator in the field. His work promises to have a lasting impact on the treatment of mycobacterial infections and HPV-related conditions.